Fidelity
Home > Boards > US Listed > Biotechs > Ariad Pharmaceuticals, Inc. (ARIA)

That would be logical once the anecdotal reports

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
vidpok45 Member Profile
 
Followed By 10
Posts 2,359
Boards Moderated 1
Alias Born 06/15/10
160x600 placeholder
ARIAD to Webcast Conference Call on First Quarter 2014 Financial Results "Business Wire" - 4/16/2014 7:35:00 AM
Clinical Trial Results and Initiation, Endowment, Product Launches, and Appointments - Analyst Notes on Regeneron, Questcor, ... "PR Newswire (US)" - 4/11/2014 8:00:00 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 4/9/2014 10:05:50 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2014 4:32:48 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2014 4:31:56 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2014 4:31:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2014 4:30:14 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2014 4:29:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2014 4:29:08 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/3/2014 4:28:20 PM
Clinical Study Initiations, Stock Price Updates, and Strategic Agreements - Analyst Notes on Ariad, Jazz, Intercept, Communit... "PR Newswire (US)" - 4/2/2014 8:00:00 AM
ARIAD Announces Appointment of Hugh Cole, Senior Pharmaceutical-Industry Executive, as Chief Business Officer "Business Wire" - 4/2/2014 7:35:00 AM
Technical Pointers on Top Gainers -- Research on ARIAD Pharma, Arotech, Restoration Hardware Holdings, and Sprouts Farmers Ma... "PR Newswire (US)" - 3/31/2014 12:52:00 PM
ARIAD startet Phase-2-Zulassungsstudie ALTA für AP26113 an Patienten mit nicht-kleinzelligem Lungenkrebs "Business Wire" - 3/25/2014 9:22:00 AM
ARIAD annonce le démarrage de l’essai pivot de Phase 2 « ALTA » portant sur l’AP26113 administré à des patients at... "Business Wire" - 3/25/2014 9:21:00 AM
ARIAD Announces Initiation of Pivotal Phase 2 ALTA Trial of AP26113 in Patients with Non-Small Cell Lung Cancer "Business Wire" - 3/24/2014 7:35:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2014 5:31:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2014 5:29:23 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2014 5:28:56 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2014 5:22:03 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2014 5:21:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2014 4:12:07 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2014 4:11:12 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/21/2014 4:10:04 PM
Financial Results, Clinical Study Updates, Clinical Trial Results, Business Spin-Offs, and New Joint Ventures - Analyst Notes... "PR Newswire (US)" - 3/12/2014 8:00:00 AM
vidpok45   Tuesday, 05/15/12 08:11:15 PM
Re: ariadndndough post# 18930
Post # of 48730 
That would be logical once the anecdotal reports can be validated.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist